Bariatric surgery is an effective intervention for management of obesity through treating
dysregulated appetite and achieving long-term weight loss maintenance. Moreover …

Obesity is a complex, multifactorial disease that is a major public health issue worldwide.
Currently approved anti-obesity medications and lifestyle interventions lack the efficacy and …

Enhanced secretion of glucagon-like peptide 1 (GLP-1) seems to be essential for improved
postprandial β-cell function after Roux-en-Y gastric bypass (RYGB) but is less studied after …

Roux-en-Y gastric bypass (RYGB) improves, and can sometimes resolve, non-alcoholic fatty
liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) but data based on …

Bariatric surgery determines a rearrangement of the gastrointestinal tract that influences
nutrient handling and plays a role in the metabolic changes observed after surgery. Most of …

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing, as are other
manifestations of metabolic syndrome such as obesity and type 2 diabetes. NAFLD is …

Continuously rising trends in diabetes render this disease spectrum an epidemic proportion
worldwide. As the disease progresses, the pathological effects of diabetes may impair the …

Background The duodenum has emerged as a key player in metabolic diseases. The
objective was to evaluate the safety and efficacy of intra-duodenal PDT using methylene …

Background Altered bile acid (BA) turnover has been suggested to be involved in the
improved glucose regulation after Roux-en-Y gastric bypass (RYGB), possibly via …

Obesity and type-2 diabetes mellitus (T2DM) are metabolic disorders. Obesity increases the
risk of T2DM, and as obesity is becoming increasingly common, more individuals suffer from …